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ABSTRACT: Sac family phosphoinositide phosphatases
comprise an evolutionarily conserved family of enzymes in
eukaryotes. Our recently determined crystal structure of the
Sac phosphatase domain of yeast Sac1, the founding member
of the Sac family proteins, revealed a unique conformation of
the catalytic P-loop and a large positively charged groove at the
catalytic site. We now report a unique mechanism for the
regulation of its phosphatase activity. Sac1 is an allosteric
enzyme that can be activated by its product phosphatidylino-
sitol or anionic phospholipid phosphatidylserine. The activation of Sac1 may involve conformational changes of the catalytic P-
loop induced by direct binding with the regulatory anionic phospholipids in the large cationic catalytic groove. These ﬁndings
highlight the fact that lipid composition of the substrate membrane plays an important role in the control of Sac1 function.
P
hosphoinositides (PIs), a collection of seven biologically
active and interconvertable phosphatidylinositol deriva-
tives, are minor yet essential components of the cytosolic leaﬂet
of eukaryotic cell membranes. In response to acute signaling
inputs, phosphorylation or dephosphorylation of PIs provides
spatial and temporal cues within the cell for PI binding
proteins, which in turn promote the assembly of macro-
molecular complexes and initiate physiological events, including
membrane traﬃcking and actin dynamics. Moreover, in
response to extracellular stimuli, PIs can serve as precursors
for several types of second messengers in multiple intracellular
signaling pathways.
1−3 The acute conversion between diﬀerent
PI derivatives is mediated by a large number of PI kinases and
phosphatases.
The Sac domain-containing proteins make up an essential
family of PI phosphatases. Members of this family include the
transmembrane protein Sac1, as well as the cytoplasmic
proteins Sac2/Inpp5f, Sac3/Fig4, and several synaptojanin
homologues. The founding member of this PI phosphatase
family, yeast Sac1p, an integral membrane protein, was
identiﬁed more than 20 years ago.
4,5 Since then, considerable
progress on this enzyme has been made from yeast to
mammals, as well as plants.
6−12 Sac1 is an ER/Golgi-localized
PI phosphatase that plays a major role in regulating
phosphatidylinositol 4-phosphate [PI(4)P] metabolism.
6,13 It
has been shown that Sac1 is essential for the development of
multicellular organisms,
9,10,14 and the deletion of Sac1 in yeast
results in a broad spectrum of functional defects, including
impaired membrane traﬃcking, an abnormal actin cytoskeleton,
and altered lipid metabolism.
15
Sac1 is conserved in all eukaryotes with an N-terminal
cytoplasmic Sac homology domain, a central unstructured
linker region, and two C-terminal transmembrane motifs.
Recently, the crystal structure of the Sac1 cytoplasmic domain
has been determined.
16 The structure revealed that the Sac
homology domain is comprised of two closely packed
subdomains: a novel N-terminal subdomain and the catalytic
phosphoinositide phosphatase subdomain. Unlike other
CX5RT/S-based PI phosphatases, such as PTEN
17 or
MTM,
18 Sac1 has a large positively charged groove at the
catalytic site. In addition, the catalytic P-loop of Sac1 has a
striking conformation in that the catalytic cysteine is far from
the conserved arginine that functions to bind the releasing
phosphate group.
16 These structural ﬁndings suggest that a
conformational change of the catalytic P-loop may be required
to achieve a functional arrangement of the catalytic residues. It
is likely that other protein factors or lipid components are
needed for the activation of Sac1. Recent studies have shown
that a group of oxysterol binding homology (Osh) proteins
activates Sac1 at the ER−plasma membrane contact sites.
19
However, it is not known whether Sac1 phosphatase activity
can be regulated by the lipid environment of its targeting
membrane bilayer.
To understand the intrinsic enzymatic properties and
regulation of Sac1, we performed in vitro kinetic studies of
the phosphatase domain of Sac1. We found that Sac1 is an
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anionic phospholipids, phosphatidylinositol (PtdIns) and
phosphatidylserine (PS). We propose that the PI phosphatase
activity of Sac1 is intrinsically regulated by the lipid
composition of the membrane bilayer where Sac1 acts.
■ MATERIALS AND METHODS
Materials. diC16 PI(4)P, diC16 PI(4,5)P2, diC16 PtdIns,
diC16 PA, and diC8 PS were obtained from Avanti Polar Lipids,
Inc. POPC and POPS were from NOF America Corp. All other
diC8 lipids and inositol phosphates were purchased from
Cellsignals Inc. (Columbus, OH).
Mutagenesis, Recombinant Protein Expression, and
Puriﬁcation. DNA sequence corresponding to amino acids 1−
511 of yeast Sac1 was ampliﬁed via polymerase chain reaction
and cloned into a pET28-based bacterial expression vector in
frame with an N-terminal six-His-sumo tag. The recombinant
fusion protein was expressed in BL21 cells. Cells were
harvested and lysed by sonication in phosphate-buﬀered saline
(PBS). The lysate was clariﬁed by centrifugation, and the
supernatant was collected and passed through a column packed
with cobalt aﬃnity beads (Clontech). The column was
extensively washed with PBS and eluted with 200 mM
imidazole in PBS. The tag was removed by Ulp1 sumo speciﬁc
protease, and the recombinant protein was further puriﬁed by
size exclusion chromatography. The puriﬁed protein was stored
at −80 °C in storage buﬀer [50 mM Tris (pH 6.8), 150 mM
NaCl, 2 mM DTT, and 50% glycerol]. Sac1 mutants were
generated by site-directed mutagenesis, and the constructs were
veriﬁed by sequencing. The mutant proteins were expressed
and puriﬁed as described above.
Preparation of Phospholipid Vesicles. Long fatty acid
chain lipids were dissolved in a solution containing 90%
chloroform and 10% methanol. An appropriate amount of lipids
solution was mixed in a glass vial according to the composition
of the liposome. The lipids were then dried under a nitrogen
stream and rehydrated with enzyme reaction buﬀer [50 mM
Tris (pH 6.8), 150 mM NaCl, and 2 mM DTT] at 37 °C for 1
h. The resulting multilamellar liposome was extruded through a
30 nm pore diameter polycarbonate ﬁlter (WaterMan) using a
Mini-Extruder device (Avanti) to obtain unilamellar vesicles.
Enzymatic Assays. Because the short acyl chain lipids can
form micelles at high concentrations, it is critical to ensure the
substrate or the activators are below their critical micelle
concentration (CMC) in our assay with water-soluble lipids. It
has been shown that diC8 PS has a CMC of 2.28 mM.
20 The
CMC of PtdIns was reported to be ∼0.5 mM.
21 Although the
CMC of diC8 PI(4)P is still unknown, the CMC of diC8 PI(3)P
is ∼0.7 mM;
21 thus, it is safe to estimate that the CMC of diC8
PI(4)P should also be ∼0.7 mM. Other phospholipids, such as
PI(4,5)P2, should have a CMC value of >0.7 mM because of
the larger and highly charged headgroup. The concentrations of
the lipids used in our enzymatic assays are all signiﬁcantly
below the CMC values. We expect that the lipid substrates or
activators should be monodisperse and do not form micelles in
our assays.
Before the enzymatic assay, Sac1 proteins from −80 °C
storage were ﬁrst diluted with reaction buﬀer to make an
enzyme reaction stock (0.1 mg/mL or 1.8 μM). For all the
reactions, except for the experiments designed to test the eﬀects
of enzyme concentration, the enzyme was further diluted 50
times to a ﬁnal concentration of 36 nM. All the reaction
mixtures were incubated at room temperature. An aliquot of the
reaction mixture was taken out and mixed with 50 mM N-
ethylmaleimide (NEM) to stop the reaction. Phosphate release
was measured by the addition of malachite green reagent and
absorbance at OD620. To obtain the initial velocities of the
reactions, a series of reaction progress curves was recorded at
diﬀerent substrate concentrations. Initial velocities were derived
using Dynaﬁt
22 and then plotted against the substrate
concentrations using GraphPad Prism version 5 (http://www.
graphpad.com/prism).
Analytical Ultracentrifugation. Sedimentation velocity
analytical ultracentrifugation experiments were performed on a
Beckman Proteomelab XL-A analytical ultracentrifuge at 10 °C.
Protein samples were diluted with 20 mM HEPES, 20 mM
NaCl, and 2 mM TCEP to a concentration of 1 or 0.1 mg/mL;
300 scans were collected at 50,000 rpm (200,000 g) and 230
nm with the time interval between scans set to zero.
Sedimentation boundaries were analyzed by the continuous
distribution method [c(S)] using SEDFIT.
23 SEDNTERP
24
was used to correct experimental S values (s) to standard
conditions at 20 °C in water (S20,w) and to calculate the partial
speciﬁc volume of Sac1.
Yeast Strains, Fluorescence Microscopy, and PI
Analysis. Yeast strains used in this study are described in
Table S1 of the Supporting Information. Plasmid pRS415-
pGPD-mCherry-2xPHOsh2, which expresses mCherry-labeled
tandem PH domains from the yeast Osh2 protein, was used as
an in vivo PI(4)P biosensor reporter.
19 Microscopy was
performed on midlog cultures at room temperature. Images
were obtained with a DeltaVision system and were deconvolved
with softWoRx. For in vivo PI level analysis, yeast strains
incubated at the indicated temperatures were labeled with [3H]-
myo-inositol. Lipids were extracted and deacylated for analysis
by high-performance liquid chromatography (HPLC) as
described previously.
25
■ RESULTS
Sac1 Is an Allosteric Enzyme. The phosphatase domain
of Sac1 has promiscuous substrate speciﬁcity in vitro. In
agreement with previous results,
7,26,27 we found that Sac1
prefers to act on PI(5)P, PI(4)P, PI(3)P, with low activity on
PI(3,5)P2, and with no activity on other phosphoinositides,
such as PI(4,5)P2, PI(3,4)P2, and PI(3,4,5)P3, or inositol
polyphosphates (Figure S1A of the Supporting Information).
Furthermore, unlike other inositol polyphosphate phospha-
tases,
28 divalent ions, such as Mg2+,C a 2+, and Mn2+, have no
obvious eﬀect on the activity of Sac1 (Figure S1B of the
Supporting Information). Because the major substrate of Sac1
in vivo is PI(4)P,
6,8,29 we used water-soluble diC8 PI(4)P,
which has two C8 fatty acid chains, or liposome-embedded
brain diC16 PI(4)P (Avanti) as the substrate in all of the
following kinetic experiments.
The kinetics of hydrolysis of diC8 PI(4)P by Sac1 were
evaluated by an end point chromogenic assay based on a
modiﬁed version of the malachite green method as described
previously.
30 Initial velocities were derived from series of
reaction progress curves at diﬀerent substrate concentrations
with a ﬁxed amount of enzyme (36 nM) and plotted against
PI(4)P concentration (Figure 1A). Interestingly, the reaction
does not follow simple Michaelis−Menten kinetics; instead, the
velocity data assumed a sigmoidally shaped curve, and thus, the
data were ﬁt to the Hill equation: v = Vmax
h[S]/[S]h + K0.5
h
(where v is the initial velocity, h is the Hill coeﬃcient, and K0.5
is the substrate concentration at which v is half-maximal). The
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μM. Sigmoidal kinetics can arise from many possibilities, such
as the oligomeric state of the enzyme, multiple catalytic sites, or
slow conformational changes.
31,32
Enzyme Oligomerization Is Not Responsible for the
Sigmoidal Kinetic Behavior of Sac1. To test whether Sac1
can form oligomers in solution, we used sedimentation velocity
analytic ultracentrifugation (AUC) to examine the solution
behavior of Sac1. At 1 mg/mL (18 μM), the enzyme exhibited
two peaks with sedimentation coeﬃcients of 3.1 S (3.2 S20,w,5 5
kDa) and 4.3 S (4.4 S20,w, 96 kDa), corresponding to
monomeric (80%) and dimeric (20%) forms of the protein,
respectively (Figure 1B, solid line). However, 95% of the
protein is monomeric when the protein concentration is
reduced to 0.1 mg/mL (1.8 μM) (Figure 1B, dashed line). In
our enzymatic assays, the ﬁnal enzyme concentration is only 2
μg/mL (36 nM). These data suggest that Sac1 predominantly
exists as a monomer under our assay conditions. We further
investigated the correlation between the enzyme activity and its
concentration. Sac1 enzymatic assays were conducted with the
same amount of substrate but diﬀerent enzyme concentrations
(Figure S2A,B of the Supporting Information). Plotting of the
initial velocities versus the enzyme concentration resulted in a
linear line, indicating that the catalytic activity of Sac1 has no
sigmoidal dependence on enzyme concentration. This result
further suggests that the sigmoidal kinetics observed for Sac1 is
not due to its oligomerization.
Allosteric Activation of Sac1 by Anionic Phospholi-
pids. It has been reported that allosteric enzymes can be
activated by their products to form a positive feedback
loop.
33,34 In our reaction system, the product is phosphatidy-
linositol (PtdIns). We asked whether PtdIns is an activator for
Sac1. To examine the eﬀect of PtdIns, the PI(4)P substrate
concentration was held constant at 20 μM while the
concentration of PtdIns was varied. A series of progress curves
were recorded, and the initial velocities extracted from each
progress curve were plotted versus PtdIns concentration
(Figure 2A). Indeed, the activity of Sac1 was stimulated by
the addition of PtdIns, and the activation reached saturation at
∼50 μM PtdIns. Furthermore, the activation of Sac1 was not
d u et oe n z y m eo l i g o m e r i z a tion because Sac1 remained
Figure 1. Sac1 is an allosteric enzyme. (A) Concentration dependence
of PI(4)P hydrolysis. Initial velocities were determined from reaction
progress curves and were plotted vs substrate concentration (x-axis).
The data were ﬁt to the Hill equation. The Hill coeﬃcient h is 4.5 ±
0.3, and the K0.5 is 16 ± 2 μM. (B) Sedimentation velocity AUC
measurements of Sac1 in solution at diﬀerent concentrations [1 ()
and 0.1 mg/mL (---)]. The diﬀerential sedimentation coeﬃcient
distribution c(s) is plotted vs the sedimentation coeﬃcient. Sac1 is
predominantly in the monomeric form (95%) at a protein
concentration of 0.1 mg/mL (---).
Figure 2. Allosteric activation of Sac1 by its product PtdIns. (A)
Concentration-dependent activation of Sac1 by PtdIns. The reactions
were conducted with a ﬁxed amount of substrate PI(4)P and varying
amounts of PtdIns. Initial velocities obtained from each progress curve
were plotted vs PtdIns concentration. (B) PI(4)P hydrolysis in the
presence of 50 μM diC8 PtdIns (●). The initial velocity data were
plotted and ﬁt to the Michaelis−Menten equation. Full activation of
Sac1 by PtdIns results in a hyperbolic kinetic curve. For comparison,
the kinetic curve without an activator (▽, the same curve shown in
Figure 1A) is also plotted on the same scale. (C) Sedimentation
velocity AUC measurements of Sac1 in solution. Diﬀerential
sedimentation coeﬃcient distribution c(s) plotted vs sedimentation
coeﬃcient. Experiments were conducted with a protein concentration
of 0.1 mg/mL in the absence of PtdIns () or in the presence of 20
(−−−)o r5 0μM diC8 PtdIns (···).
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shown by sedimentation velocity measurements (Figure 2C).
These results suggest that PtdIns may function as an allosteric
activator. The data further predict that if all the enzyme
molecules are fully activated by the addition of PtdIns, the
reaction should follow simple Michaelis−Menten kinetics.
Indeed, when PtdIns was kept at a ﬁxed concentration (50
μM) in our reaction system, the plot of initial velocity versus
PI(4)P substrate concentration changed to a hyperbolic curve
(Figure 2B) that is distinct from the sigmoidal curve observed
in the absence of an activator. These kinetic results, together
with previous structure information, suggest that the enzyme
may have heterogeneous conformations in solution and the
unique catalytic P-loop may be involved in a slow conforma-
tional change sampling between an inactive form (observed in
our crystal structure) and the active form (seen in other lipid
phosphatases, such as PTEN).
16 When activators bind, the
balance is favored toward the active form.
Allosteric activation of Sac1 by PtdIns raised the question
about the speciﬁcity of activators. PtdIns is an anionic lipid with
a net charge of −1. We asked whether other negatively charged
phospholipids could also activate the enzyme. We performed
enzymatic assays in the presence of other water-soluble
phospholipids and a ﬁxed amount of PI(4)P. We found that
short chain phosphoinositol derivatives, such as PI(4,5)P2 and
PI(3,4)P2, did not activate the enzyme. However, Sac1 is
strongly activated by phosphatidylserine (PS) (Figure S3A,B of
the Supporting Information). To further investigate the
activation of Sac1 by PS, we performed kinetic assays similar
to the PtdIns activation experiments described above.
Interestingly, a sigmoidal PS concentration-dependent rate
curve was observed (Figure S4A of the Supporting
Information), and the enzyme can be fully activated at a PS
concentration of 20 μM. When the enzyme was fully activated
by 20 μM PS, a hyperbolic rate curve of initial velocitie versus
PI(4)P concentration was obtained (Figure S4B of the
Supporting Information). These kinetic data suggest that the
activity of Sac1 can be stimulated by anionic phospholipids
PtdIns and PS. The biological signiﬁcance of this activation will
be further discussed below.
Conserved Residues That Aﬀect the Kinetics of Sac1.
To further investigate the allosteric mechanism of Sac1, we
utilized structure information about Sac1 and created
substitutions to perturb the catalytic behavior of Sac1. The
surface of Sac1 that contains the catalytic site has a deep
cationic groove (Figure 3A). The catalytic P-loop assumes a
unique conformation.
16 In that conformation, the catalytic
C392 is far from R398, which holds the releasing phosphate
group on substrates. A conformational change of the P-loop
seems to be required to bring C392 and R398 close enough to
form a functional catalytic site. We introduced substitutions of
several conserved residues, including R207Q, R256Q, C392S,
D394N, D397N, and R398Q, that align inside the cationic
groove (Figure 3A). R207 and R256 are the major residues that
contribute to the cationic properties of the groove. The other
residues are components of the catalytic P-loop. Recombinant
proteins were expressed and puriﬁed as described for the wild-
type protein. All mutant proteins were stable and displayed a
proﬁle similar to that of the wild-type protein as determined by
gel ﬁltration chromatography. Although most of the mutants
have no detectable activity in our in vitro enzymatic assays,
R207Q is active but with reduced allosteric kinetics compared
Figure 3. Sac1 mutants exhibit altered kinetics. (A) Surface representative of Sac1 phosphatase. The surfaces were colored on the basis of
electrostatic potential with positively charged regions colored blue (+3 kcal/electron) and negatively charged surfaces red (−3 kcal/electron). Sac1
has a deep cationic cleft where the catalytic site resides (left). The catalytic P-loop with the unique conformation is shown as a red tube. Residues
selected for mutagenesis are labeled and shown as sticks (close-up on the right). (B) Plot of the kinetics of the R207Q mutant. The initial velocities
were plotted vs substrate concentration. Fitting with the Hill equation revealed a signiﬁcant increase in the K0.5 to ∼46 μM. (C) Hydrolysis of PI(4)P
by the Sac1 R207Q mutant in the presence of 20 μM diC8 PS. The initial velocity data were plotted and ﬁt to the Michaelis−Menten equation. (D)
Schematic diagram for the allosteric activation of Sac1. When allosteric activators such as PtdIns or PS bind, the catalytic P-loop may change its
conformation, allowing substrate binding and active catalysis by Sac1.
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versus PI(4)P concentration were sigmoidal with a Hill
coeﬃcient h of 3.6 ± 0.3, and the K0.5 was ∼46 ± 5 μM
(Figure 3B). The structure of Sac1 revealed that R207 is ∼11 Å
from the catalytic cysteine and ∼20 Å from the arginine (Figure
3A). This large distance suggests that the R207 site cannot be
the substrate binding site; instead, it may be an allosteric site. In
agreement with this idea, the R207Q mutant can be fully
activated by a high concentration (20 μM) of PS (Figure 3C),
suggesting R207 does not aﬀect substrate binding. The reduced
allosteric eﬀect of the R207Q mutation is likely due to the
reduced aﬃnity for allosteric activators. Taken together, our
structural observation and kinetic data suggest that R207 is an
allosteric site, through which the binding of potential activators
induces conformational changes in the catalytic P-loop to
activate the enzyme. We thus propose a general mechanism for
the kinetic behavior of Sac1 (Figure 3D). Sac1 is an allosteric
enzyme and is predominantly in its inactive form in the absence
of allosteric regulators. Upon binding of activators, the catalytic
P-loop changes its conformation to allow the catalytic cysteine
and arginine residues to be positioned in its proximity as seen
in other active PI phosphatases, such as PTEN, leading to active
catalysis.
17
Activation of Sac1 on the Surface of Membrane
Vesicles. The physiological substrates of Sac1 are embedded in
the membrane bilayer. We then asked whether the observed
activation of Sac1 by PtdIns or PS applies to membrane-
embedded substrates. To answer this question, liposomes were
prepared as described (see Materials and Methods). Reaction
progress curves were evaluated using liposomes with diﬀerent
lipid compositions (Figure 4A,B). When liposomes with a
PC:PI(4)P lipid ratio of 4:1 or a PC:PI(4,5)P2:PI(4)P lipid
ratio of 3:1:1 were used in the assay, the hydrolysis of PI(4)P
was barely detectable. However, when liposomes with a
PC:PtdIns:PI(4)P lipid ratio of 3:1:1, a PC:PS:PI(4)P lipid
ratio of 3:1:1, or a PC:PA:PI(4)P lipid ratio of 3:1:1 were
tested, signiﬁcant PI(4)P hydrolysis was detected in compar-
ison to liposomes lacking PtdIns, PS, or PA (Figure 4A,B).
Because PS and PI are relatively abundant phospholipids in
eukaryotic cells, we further investigated the dependency of the
enzyme activity on the mole fraction of PS and PtdIns in
liposomes. Liposomes were prepared with a ﬁxed molar ratio of
diC16 PI(4)P. The amount of PS or PtdIns was sampled from 0
to 20%, and the neutral lipid PC was adjusted accordingly to
make the rest of the fraction. The progress of the reaction was
recorded, and initial velocities were plotted (Figure 4C,D and
Figure 4. Hydrolysis of diC16 PI(4)P substrates presented in liposomes by Sac1. (A) Representative reaction progress curves of the hydrolysis of
diC16 PI(4)P in liposomes with diﬀerent lipid compositions by Sac1. (B) Activity of Sac1 toward liposomes with diﬀerent lipid compositions (n = 2).
The initial velocity data were extracted from progress curves shown in panel A. (C) Reaction progress curves of the hydrolysis of diC16 PI(4)P in
liposomes with a ﬁxed amount of PI(4)P substrate but with a diﬀerent molar fraction of PS. (D) Initial velocities obtained from panel C plotted vs
the mole fraction of PS.
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activity on PI(4)P-containing liposomes can be stimulated in a
PS or PtdIns mole fraction-dependent fashion. These data
demonstrate that the activity of Sac1 can be modulated by the
lipid composition of the membrane bilayer.
PI(4)P Levels Are Elevated in Phosphatidylserine (PS)-
Depleted Cells. The allosteric activation of Sac1 by anionic
lipids, particularly by PS, led us to predict that PI(4)P levels
should increase in cells with reduced levels of PS. We took the
advantage of the available yeast W303-1A strain, which carries
the cho1 gene deletion.
35 Yeast Cho1 is a CDP-diglyceride
serine phosphatidyltransferase and is responsible for the de
novo synthesis of PS (Figure 5A). We ﬁrst used the PI(4)P
FLARE (ﬂuorecent lipid-associated reporter) mCherry-
2xPHOsh2 to examine the localization of PI(4)P in vivo. In
wild-type cells, the PI(4)P FLARE was found at the Golgi
apparatus and the inner plasma membrane surface. However, in
cho1Δ yeast cells, which lack PS,
35 the amount of PI(4)P
FLARE was increased at the PM (Figure 5B), similar to the
localization of the PI(4)P FLARE in cells lacking Sac1.
19,36
Furthermore, analysis of [3H]inositol-labeled phospholipids
indicated that PI(4)P levels in cho1Δ cells are nearly 2-fold
higher than in wild-type cells (Figure 5C). This eﬀect was
speciﬁc for PI(4)P, as levels of other phosphoinositide isoforms
were reduced in cho1Δ cells (Table S2 of the Supporting
Information). Taken together, our results suggest that the
anionic lipid PS modulates the localization and levels of PI(4)P
in vivo, likely through the regulation of the phosphatase activity
of Sac1.
■ DISCUSSION
In this study, we report that Sac1 is an allosteric enzyme.
Although sigmoidal kinetics often indicate multimeric enzymes
with several interacting active sites, monomeric enzymes have
also been reported to display allosteric regulation.
37 In the case
of Sac1, equilibrium between the dimer and monomer was
observed in our AUC experiment at a relatively high
concentration. However, at the concentration of our enzymatic
assays, Sac1 did not exhibit any sigmoidal correlation between
its activity and concentration. Although dimerization of Sac1
may provide a regulatory mechanism,
11 the allosteric kinetics of
Sac1 that we recorded is likely not due to the oligomerization
of the enzyme. On the basis of our mutagenesis studies and the
previously published Sac1 structure,
16 we propose that Sac1 is
an allosteric enzyme. Binding of activators in the deep cationic
groove induces a conformational switch of the catalytic P-loop,
thereby activating Sac1. This intrinsic structural switch is
reﬂected macroscopically by the sigmoidal kinetic behavior of
the enzyme. Our studies further revealed that Sac1 can be
activated by anionic phospholipids PtdIns and PS. The
Figure 5. Elevated PI(4)P levels in cho1Δ yeast cells. (A) Metabolic pathway of PS. Cho1 is a phosphatidylserine synthase that catalyzes the
synthesis of PS from CDP-diaclyglycerol and L-serine. PS can be used to generate PE. CHO1-deﬁcient yeast cells are viable, provided the growth
medium is supplemented with ethanolamine that can be used to synthesize PE through the Kennedy pathway.
45(B) PI(4)P localization in wild-type
and cho1Δ cells. Cells expressing mCherry-2xPHOsh2 were observed by ﬂuorescence microscopy. Mother cells are indicated (m). The scale bar is 5
μm. (C) Cellular PI(4)P levels in wild-type and cho1Δ cells were measured by [3H]-myo-inositol labeling. Lipids from wild-type (gray) and cho1Δ
(black) cells were extracted and deacylated for analysis by HPLC. Error bars denote the standard deviation of three experiments.
Biochemistry Article
dx.doi.org/10.1021/bi300086c | Biochemistry 2012, 51, 3170−3177 3175activation of Sac1 seems to be speciﬁc as other lipids with
negatively charged headgroups, such as PI(4,5)P2 and PI(3,4)-
P2, did not activate Sac1.
Activation of an enzyme by its product has been observed in
other lipid phosphatases, including PTEN,
33,38 myotubularin
phosphatases,
34 and a secreted salivary inositol polyphosphate
5-phosphatase.
28 PtdIns is most enriched in the endoplasmic
reticulum (ER), up to 15% of total phospholipids in ER.
39
Moreover, PtdIns synthesis occurs in the ER where Sac1
resides. This may provide a mechanism for eﬃciently
maintaining low PI(4)P levels at the ER. PA is a minor
component of cell membranes. Production of PA by receptor-
stimulated phospholipase D has been shown to activate PIP 5-
kinase that converts PI(4)P to PI(4,5)P2 at the plasma
membrane.
40−42 Our results showed that PA can activate
Sac1 in vitro. However, whether PA can also stimulate Sac1
activity in vivo and the biological consequence of this potential
regulation by PA remains to be investigated. The allosteric
activation of Sac1 by PS may have interesting biological
implications. The requirement of PS for Sac1 to hydrolyze its
substrates presented on liposomes suggests that the lipid
composition of the membrane on which Sac1 acts is critical for
its enzyme activity. Consistent with this, we found that PI(4)P
levels are increased in cho1Δ mutant cells that are defective in
PS synthesis. This further implies that Sac1 may prefer to act in
a membrane environment enriched with PS. While PS is an
abundant negatively charged phospholipid in eukaryotic cells, it
is distributed unevenly within cellular membrane-bound
organelles. PS is found preferentially in the inner leaﬂet of
the plasma membrane and less abundant in other membranes,
such as the ER and Golgi compartments.
39,43 Genetic and
biochemical data have shown that Sac1 regulates a pool of
PI(4)P on the plasma membrane.
6,13 The crystal structure of
Sac1 revealed a long ﬂexible linker between the catalytic
domain and the transmembrane domains. This long linker
physically allows the ER-anchored Sac1 to function in trans on
the plasma membrane.
16 Our in vitro kinetic results support the
idea that the PS-enriched plasma membrane would be a
favorable membrane environment in which Sac1 can function.
The regulation of Sac1 activity by the anionic phospholipid PS
may also be part of a homeostatic regulatory loop that controls
the overall surface charge of the plasma membrane. In
agreement with this notion, we found that cho1Δ cells with
reduced PS levels in turn have increased levels of PI(4)P on the
inner leaﬂet of the plasma membrane. Interestingly, cells with
impaired Sac1 activity accumulate PI(4)P and in turn have
reduced levels of PS.
8,44
Allosteric enzymes possess a physiological advantage in their
ability to respond to changes in the concentration of their
substrates and products. The sigmoidal behavior of Sac1
suggests an intrinsic mechanism for the tight and acute control
of PI(4)P levels in vivo. However, control of Sac1 activity also
requires additional regulatory protein factors. Recent data have
shown that a group of oxysterol binding homology (Osh)
proteins activate Sac1 at ER−plasma membrane contact sites.
19
Our ﬁnding of the activation of Sac1 by anionic lipids adds
another layer of regulation to the maintenance of PI(4)P
homeostasis in vivo.
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